Agency Forms Undergoing Paperwork Reduction Act Review, 11576-11577 [2017-03593]

Download as PDF 11576 Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices Engagement Strategies’’, IP17–002 and ‘‘Rapid-Cycle Survey Collaborative for Provider Input on Immunization Issues’’, IP17–003. CONTACT PERSON FOR MORE INFORMATION: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–03628 Filed 2–23–17; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P asabaliauskas on DSK3SPTVN1PROD with NOTICES Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—State, Tribal, Local and Territorial (STLT) Subcommittee In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: TIME AND DATE: 10:00 a.m.–11:30 a.m., EDT, March 21, 2017. PLACE: This meeting will be held by teleconference. STATUS: This meeting is open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment, which is tentatively scheduled from 11:15 a.m.–11:20 a.m. EDT. To participate on the teleconference, please dial (855) 644– 0229 and enter code 1482483. PURPOSE: The Subcommittee will provide advice to the CDC Director through the ACD on strategies, future needs, and challenges faced by State, Tribal, Local and Territorial health agencies, and will provide guidance on opportunities for CDC. MATTERS FOR DISCUSSION: The STLT Subcommittee members will discuss progress on implementation of ACDadopted recommendations related to the Jkt 241001 Jose Montero, MD, MPH, Designated Federal Officer, STLT Subcommittee, ACD, CDC, 4770 Buford Highway, MS E70, Atlanta, Georgia 30341, Telephone (404) 498–0300, Email: OSTLTSDirector@cdc.gov. Please submit comments to OSTLTSDirector@ cdc.gov no later than March 17, 2017. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. [FR Doc. 2017–03626 Filed 2–23–17; 8:45 am] Centers for Disease Control and Prevention 17:20 Feb 23, 2017 CONTACT PERSON FOR MORE INFORMATION: Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P VerDate Sep<11>2014 health department of the future, other emerging challenges and how CDC can best support STLT health departments in the transforming health system. The agenda is subject to change as priorities dictate. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–17–0733] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Early Hearing Detection and Intervention (EHDI) Follow-up Survey (OMB Control No. 0920–0733, Expiration Date: 8/31/2016)— Reinstatement with Change—National Center on Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control and Prevention (CDC). Background and Brief Description NCBDDD promotes the health of babies, children, and adults, with a focus on preventing birth defects and developmental disabilities and optimizing the health outcomes of those with disabilities. As part of these efforts NCBDDD is actively involved in addressing the early identification of hearing loss among newborns and infants. Congenital hearing loss is a common birth defect that affects 1 to 3 per 1,000 live births, or approximately 12,000 children across the United States annually. Studies have shown that children with a delayed diagnosis of hearing loss can experience preventable delays in speech, language, and cognitive development. To ensure children with hearing loss are identified as soon as possible, many states and United States (U.S.) territories have implemented Early Hearing Detection and Intervention (EHDI) programs and enacted laws related to infant hearing screening. The majority of these EHDI programs have adopted the ‘‘1–3–6’’ plan, which consists of three core goals: (1) Screening all infants for hearing loss before 1 month of age, (2) ensuring diagnostic audiologic evaluation before 3 months of age for those who do not pass the screening, and (3) enrollment E:\FR\FM\24FEN1.SGM 24FEN1 11577 Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices in early intervention services before six months of age for those identified with hearing loss. Federal support for identifying children with hearing loss began with the Children’s Health Act of 2000, which authorized federal programs to support EHDI activities at the state level. Since then, funds have been distributed to states via cooperative agreements from the CDC and grants from the Health Resources and Services Administration (HRSA). States are using these federal monies to enhance EHDI programs and develop corresponding tracking and surveillance systems. These systems are intended to help EHDI programs ensure infants and children are receiving recommended hearing screening, follow-up, and intervention services. The mission of the CDC EHDI team is for every state and U.S. territory to have a complete EHDI tracking and surveillance system that will help ensure infants and children with hearing loss achieve communication and social skills commensurate with their cognitive abilities. As part of this mission the CDC EHDI team, in collaboration with representatives of state and U.S. territorial EHDI programs, developed seven National EHDI Goals that reflect the ‘‘1–3–6 plan’’ and address integration with the medical home (coordinated care by a medical provider) and development of tracking and surveillance systems to minimize loss to follow-up and loss to documentation. Many of the defined performance indicators for these goals involve obtaining data related to the number of children screened for hearing loss, referred for and receiving followup testing (e.g., diagnostic audiologic evaluation) and enrolled in early intervention services. The purpose of the revised survey is to obtain annual state data on the performance indicators in a consistent manner, which is needed to assess progress towards meeting the National EHDI goals. In addition, the availability of these data will better enable the CDC EHDI team to provide technical assistance to states and respond to questions by the general public, policy makers, and Healthy People 2020 officials. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name EHDI Program State Program Coordinators Contacted ......... EHDI Program State Program Coordinators who return the survey. Survey Directions ................... Survey .................................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–03593 Filed 2–23–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention asabaliauskas on DSK3SPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements (FOAs): CK17–001, ‘‘Creation of a Healthcare-Associated Infectious Disease Modeling Network to Improve Prevention Research and Healthcare Delivery’’; CK17–002, ‘‘Evaluation of Clinical Interventions, Surveillance, and Ecological Factors that Influence the Burden of Human Monkeypox in the Democratic Republic of the Congo (DRC)’’; and CK17–004, ‘‘Determining VerDate Sep<11>2014 17:20 Feb 23, 2017 Jkt 241001 and Monitoring Health Conditions Identified in the Medical Assessment of US-Bound Refugees.’’ Time and Date: 10:00 a.m.–5:00 p.m., EDT, March 28– 29, 2017 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Creation of a Healthcare-Associated Infectious Disease Modeling Network to Improve Prevention Research and Healthcare Delivery’’, CK17–001; ‘‘Evaluation of Clinical Interventions, Surveillance, and Ecological Factors that Influence the Burden of Human Monkeypox in the Democratic Republic of the Congo (DRC)’’, CK17–002; and ‘‘Determining and Monitoring Health Conditions Identified in the Medical Assessment of US-Bound Refugees’’, CK17–004. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Number of responses per respondent 59 57 Average burden per response (in hours) 1 1 10/60 240/60 Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–03647 Filed 2–23–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention ICD–10 Coordination and Maintenance (C&M) Committee Meeting National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting ICD–10 Coordination and Maintenance (C&M) Committee meeting. TIME AND DATE: 9:00 a.m.–5:00 p.m., EST, March 7–8, 2017 NAME: E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11576-11577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03593]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-17-0733]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 
Washington, DC 20503 or by fax to (202) 395-5806. Written comments 
should be received within 30 days of this notice.

Proposed Project

    Early Hearing Detection and Intervention (EHDI) Follow-up Survey 
(OMB Control No. 0920-0733, Expiration Date: 8/31/2016)--Reinstatement 
with Change--National Center on Birth Defects and Developmental 
Disabilities (NCBDDD), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    NCBDDD promotes the health of babies, children, and adults, with a 
focus on preventing birth defects and developmental disabilities and 
optimizing the health outcomes of those with disabilities. As part of 
these efforts NCBDDD is actively involved in addressing the early 
identification of hearing loss among newborns and infants. Congenital 
hearing loss is a common birth defect that affects 1 to 3 per 1,000 
live births, or approximately 12,000 children across the United States 
annually. Studies have shown that children with a delayed diagnosis of 
hearing loss can experience preventable delays in speech, language, and 
cognitive development. To ensure children with hearing loss are 
identified as soon as possible, many states and United States (U.S.) 
territories have implemented Early Hearing Detection and Intervention 
(EHDI) programs and enacted laws related to infant hearing screening. 
The majority of these EHDI programs have adopted the ``1-3-6'' plan, 
which consists of three core goals: (1) Screening all infants for 
hearing loss before 1 month of age, (2) ensuring diagnostic audiologic 
evaluation before 3 months of age for those who do not pass the 
screening, and (3) enrollment

[[Page 11577]]

in early intervention services before six months of age for those 
identified with hearing loss.
    Federal support for identifying children with hearing loss began 
with the Children's Health Act of 2000, which authorized federal 
programs to support EHDI activities at the state level. Since then, 
funds have been distributed to states via cooperative agreements from 
the CDC and grants from the Health Resources and Services 
Administration (HRSA). States are using these federal monies to enhance 
EHDI programs and develop corresponding tracking and surveillance 
systems. These systems are intended to help EHDI programs ensure 
infants and children are receiving recommended hearing screening, 
follow-up, and intervention services.
    The mission of the CDC EHDI team is for every state and U.S. 
territory to have a complete EHDI tracking and surveillance system that 
will help ensure infants and children with hearing loss achieve 
communication and social skills commensurate with their cognitive 
abilities. As part of this mission the CDC EHDI team, in collaboration 
with representatives of state and U.S. territorial EHDI programs, 
developed seven National EHDI Goals that reflect the ``1-3-6 plan'' and 
address integration with the medical home (coordinated care by a 
medical provider) and development of tracking and surveillance systems 
to minimize loss to follow-up and loss to documentation. Many of the 
defined performance indicators for these goals involve obtaining data 
related to the number of children screened for hearing loss, referred 
for and receiving follow-up testing (e.g., diagnostic audiologic 
evaluation) and enrolled in early intervention services.
    The purpose of the revised survey is to obtain annual state data on 
the performance indicators in a consistent manner, which is needed to 
assess progress towards meeting the National EHDI goals. In addition, 
the availability of these data will better enable the CDC EHDI team to 
provide technical assistance to states and respond to questions by the 
general public, policy makers, and Healthy People 2020 officials.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
EHDI Program State Program              Survey Directions.......              59               1           10/60
 Coordinators Contacted.
EHDI Program State Program              Survey..................              57               1          240/60
 Coordinators who return the survey.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-03593 Filed 2-23-17; 8:45 am]
BILLING CODE 4163-18-P